Article
Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug-Eluting Stent Implantation.
Clinical pharmacology and therapeutics - 1 Apr 2026
Park Hyun Woong, Lee Jae-Hwan, Jeong Jin-Ok, Gorog Diana A, Tantry Udaya S, Kim Byeong-Keuk, Joo Hyung Joon, Chang Kiyuk, Hwang Jin-Yong, Song Young Bin, Ahn Sung Gyun, Suh Jung-Won, Choi Woong Gil, Cho Jung Rae, Kang Jeehoon, Lee Sang Yeub, Kim Hyo-Soo, Kim Moo Hyun, Lim Do-Sun, Shin Eun-Seok, Gurbel Paul A, Jeong Young-Hoon
Abstract excerpt
The impact of CYP2C19 genotype in relation to clinical risk is unclear during clopidogrel treatment following drug-eluting stent (DES) implantation. This study aimed to evaluate the prognostic significance of CYP2C19 genotypes based on clinical risk stratification in DES-treated patients. From the nationwide multicenter PTRG-DES (Platelet function and genoType-Related long-term progGosis in DES-treated patients)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
